Literature DB >> 3126530

Piracetam elevates muscarinic cholinergic receptor density in the frontal cortex of aged but not of young mice.

H Pilch1, W E Müller.   

Abstract

Chronic treatment (2 weeks) with piracetam (500 mg/kg, once daily PO) elevated m-cholinoceptor density in the frontal cortex of aged (18 months) female mice by about 30-40%, but had no effect on m-cholinoceptor density in the frontal cortex of young (4 weeks) mice. The effect of piracetam on m-cholinoceptor density as determined by the specific binding of tritiated QNB was not affected by concomitant daily treatment with either choline (200 mg/kg) or scopolamine (4 mg/kg). It is concluded that the effect of piracetam on m-cholinoceptor density could explain the positive effects which have been reported for combinations of cholinergic precursor treatment with piracetam on memory and other cognitive functions in aged experimental animals and patients and could also represent part of the possible mechanism of action of piracetam alone.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3126530     DOI: 10.1007/bf00735884

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

Review 1.  Control of brain neurotransmitter synthesis by precursor availability and nutritional state.

Authors:  R J Wurtman; J D Fernstrom
Journal:  Biochem Pharmacol       Date:  1976-08-01       Impact factor: 5.858

2.  Interaction of piracetam with several neurotransmitter receptors in the central nervous system. Relative specificity for 3H-glutamate sites.

Authors:  B Bering; W E Müller
Journal:  Arzneimittelforschung       Date:  1985

3.  Piracetam combined with lecithin in the treatment of Alzheimer's disease.

Authors:  J H Growdon; S Corkin; F J Huff; T J Rosen
Journal:  Neurobiol Aging       Date:  1986 Jul-Aug       Impact factor: 4.673

4.  Reduced muscarinic receptor plasticity in frontal cortex of aged rats after chronic administration of cholinergic drugs.

Authors:  N W Pedigo; D M Polk
Journal:  Life Sci       Date:  1985-10-14       Impact factor: 5.037

5.  Cholinergic receptor loss in brains of aging mice.

Authors:  G Freund
Journal:  Life Sci       Date:  1980-02-04       Impact factor: 5.037

6.  Clinical response to choline plus piracetam in senile dementia: relation to red-cell choline level.

Authors:  E Friedman; K A Sherman; S H Ferris; B Reisberg; R T Bartus; M K Schneck
Journal:  N Engl J Med       Date:  1981-06-11       Impact factor: 91.245

7.  Membrane fluidization increases low-affinity muscarinic receptor binding in brain: changes with aging.

Authors:  G Freund; T R Brophy; J D Scott
Journal:  Exp Gerontol       Date:  1986       Impact factor: 4.032

8.  Habituation of exploratory activity in mice: effects of combinations of piracetam and choline on memory processes.

Authors:  A Platel; M Jalfre; C Pawelec; S Roux; R D Porsolt
Journal:  Pharmacol Biochem Behav       Date:  1984-08       Impact factor: 3.533

9.  Centrophenoxine-induced increase of beta-adrenoceptor density in brain cortex of old mice.

Authors:  C Viticchi; S Gentile; L Piantanelli
Journal:  Arch Gerontol Geriatr       Date:  1984-05       Impact factor: 3.250

10.  Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type.

Authors:  R Quirion; J C Martel; Y Robitaille; P Etienne; P Wood; N P Nair; S Gauthier
Journal:  Can J Neurol Sci       Date:  1986-11       Impact factor: 2.104

View more
  4 in total

1.  Cerebral-activating (EEG) properties of two inverse agonists and of an antagonist at the benzodiazepine receptor in the rat.

Authors:  V Santucci; M Fournier; P Worms; P Keane; K Bizière
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

Review 2.  Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders.

Authors:  M W Vernon; E M Sorkin
Journal:  Drugs Aging       Date:  1991-01       Impact factor: 3.923

Review 3.  Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders.

Authors:  Andrei G Malykh; M Reza Sadaie
Journal:  Drugs       Date:  2010-02-12       Impact factor: 9.546

Review 4.  Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic.

Authors:  Noor Azuin Suliman; Che Norma Mat Taib; Mohamad Aris Mohd Moklas; Mohd Ilham Adenan; Mohamad Taufik Hidayat Baharuldin; Rusliza Basir
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-30       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.